Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 16, Art. 55 (pp. 596-608)    |    2015       

»

Modification of the concept of cardiovascular continuum based upon co-morbidity and metainflammation views

Kovalchuk E.Y., Kostenko V.A., Soroka V.V., Alexeenko O.V.

State Budgetary Institution “St.-Petersburg Scientific Research
Institute for Emergency Care” named after I.I.Dzhanelidze

Brief summary

Lead cause of death worldwide last years are cardiovascular diseases. Co-morbidities as hypertension, metabolic syndrome, diabetes mellitus, chronic obstructive pulmonary disease play key role in their progression. All mentioned conditions are closely connected with the syndrome of chronic torpid systemic inflammation or metainflammation. It`s rational to add this term to the well-known concept of cardiovascular continuum. Article submitted presents modification of this concept taking into account the new information.


Key words

cardiovascular diseases, co-morbidities, systemic inflammation, metainflammation, cardiovascular continuum

Reference list

1. Egger G. In search of a germ theory equivalent for chronic disease / G.Egger // Prev. Chronic Dis. - 2012. - Vol. 9. - Art. 110301.


2. Fuster V. Promoting cardiovascular health in the developing world: A Critical challenge to achieve global health / V.Fuster, B.B.Kelly. - Washington (DC): National Academies Press (US), 2010. - 484 p.


3. Go A.S. Heart disease and srtoke statistics-2-13 Update: A report from the American Heart Association / A.S.Go, D.Mozaffarian, V.L.Roger et al. // Circ. - 2013. - Vol. 127, suppl. E. - P. e6-e245.


4. Finegold J.A Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations / J.A.Finegold, P.Asaria, D.P.Francisa // Int. J. Cardiol. - 2013. - Vol. 168, N 2. - P. 934-945.


5. Lloyd-Jones D. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association / D.Lloyd-Jones, R.J.Adams, T.M.Brown et al. // Circ. - 2010. - Vol. 121, N 7. - P. 948-954.


6. Chen H.Y. The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective / H.Y.Chen, J.S.Saczynski, D.D.McManus et al. // Clin Epidemiol. - 2013. - Vol. 5. - P. 439-448.


7. Schramm T.K. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study / T.K.Schramm, G.H.Gislason, A.Vaag et al. // Eur. Heart J. - 2011. - Vol. 32, N 15. - P. 1900-1908.


8. Vertkin A.L. Komorbidnost / A.L.Vertkin, A.S.Skotnikov // Lechashii vrach. - 2013. - № 8. - S. 78-82.


9. Mutasingwa D.R. How applicable are clinical practice guidelines to elderly patients with comorbidities? / D.R.Mutasingwa, H.Ge, R.E.Upshur // Can. Fam. Physician. - 2011. - Vol. 57, N 7. - P. e253-e262.


10. Lazzeri C. Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes / C.Lazzeri, S.Valente, M.Chiostri et al. // Heart Vessel. - 2012. - Vol. 27, N 4. - P. 370-376.


11. Schmidt M. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study / M.Schmidt, J.Bonde Jacobsen, T.L.Lash // BMJ. - 2012. - Vol. 344, suppl. E. - P. e356-e364.


12. Mukai N.Trends in the prevalence of type 2 diabetes and prediabetes in community-dwelling Japanese subjects: The Hisayama Study / N.Mukai,Y.Doi, T.Ninomiya et al. // J. Diabetes Investigation. 2014. - Vol. 5, is. 2. - P. 162-169.


13. Danaei G. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants / Danaei G., Finucane M.M., Lu Y. et al. // Lancet. - 2011. - Vol. 378, N 9785. -P. 31-40.


14. Halestrap A.P. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection / A.P.Halestrap // Biochem. Soc. Trans.  - 2010. - Vol.  38, N 4. - P.841-860.


15. Jorgensen C.H. Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention–a retrospective nationwide cohort study / C.H.Jorgensen, G.H.Gislason, C.Andersson et al. // Cardiovasc. Diabetol. - 2010. - Vol. 9. - Art. 54.


16. Atkins R.C. Diabetic kidney disease: act now or pay later / R.C.Atkins, P.Zimmet // Nephrol. Dial. Transplant. - 2010. - Vol. 25, is. 2. - P. 331-333.


17. De Cosmo S. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes / S.De Cosmo, M.C.Rossi, F.Pellegrini et al. // Nephrol. Dial. Transplant. - 2014. - Vol. 29, N 3. - P. 657-662.


18. Go A.S. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease / A.S.Go, N.Bansal, M.Chandra // J. Amer. Coll. Cardiol. - 2011. - Vol. 58, N 15. - P. 1600-1607.


19. Hall M.E. Obesity, hypertension, and chronic kidney disease / M.E.Hall, J.M. do Carmo, A.A. da Silva et al. // Int. J. Nephr. Renovasc. Disease. - 2014. - Vol. 7. - P. 75-88.


20. Lankhorst Ch.E. Anemia in renal disease: Diagnosis and management / Ch.E.Lankhorst, J.B.Wish // Blood Rev. - 2010. - Vol. 24. - P. 39-47.


21. Volgina G. Vnekostnaya kalcifikaciya y pacientov s hronicheskoi boleznu pochek / G.Volgina, D.Seleznev, O.Balkarova, E.Lovchinskii // Vrach. 2012. № 7. S. 2-8.


22. Belyalov F.I. Dvenadcat tezisov komorbidnosti / F.I.Belyalov // Klinich. medicina. - 2009. - № 12. - S. 69-71.


23. Tonelli M. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study / M.Tonelli, P.Muntner, A.Lloyd et al. // Lancet. - 2012. - Vol. 380, N 9844. - P. 807-814.


24. Nauta S.J. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era / S.J.Nauta, R.T. van Domburg, R.-J.Nuis et al. // Kidney Intern. - 2013. - Vol. 84. - P. 353-358.


25. Shroff G.R. Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? / G.R.Shroff, Ch.A.Herzog // Kidney Intern. - 2013. - Vol. 84. - P. 230-233.


26. Make B. Undertreatment of COPD: a retrospective analysis of US managed care and medicare patients / Make B., Dutro M.P., Paulose-Ram R. et al. // Int. J. Chron. Obstruct. Pulmon. Dis. - 2012. - Vol. 7. - P. 1-9.


27. Sin D.D. Is COPD really a cardiovascular disease? / D.D.Sin // Chest. - 2009. - Vol. 136, N 2. - P. 329-330.


28. Müllerova H. Cardiovascular comorbidity in COPD: Systematic literature review / H.Müllerova, A.Agusti, S.Erqou, D.W.Mapel // Chest. - 2013. - Vol. 144, N 4. - P. 1163-1178.


29. Bygaenko V.V. Komorbidnie sostoyaniya: ishemicheskaya bolezn serdca i hronicheskoe obstryktivnoe zabolevanie legkih / V.V.Bygaenko, V.A.Slobodskoi, V.V.Tovstyha // Ykraїnskii kardіologіchnii jyrnal. - 2011. - № 5. - S. 72-78.


30. Cavaillès A. Comorbidities of COPD / A.Cavaillès, G.Brinchault-Rabin, A.Dixmier et al. // Eur. Respir. Rev. - 2013. - Vol. 22, N 130. - P. 454-475.


31. Lavie C.J. Impact of obesity on outcomes in myocardial infarction: Combating the "Obesity Paradox" / C.J.Lavie, R.V.Milani, H.O.Ventura // J. Amer. Coll. Cardiol. - 2011. - Vol. 58, N 25. - P. 2651-2653.


32. Yusuf S. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study / S.Yusuf, S.Hawken, S.Ounpuu et al. // Lancet. - 2005. - Vol. 366, N 9497. - P. 1640-1649.


33. Xi B. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009 / B.Xi, Y.Liang, T.He et al. // Obes Rev. - 2012. - Vol. 13, N 3. - P. 287-296.


34. Li C. Increasing trends in waist circumference and abdominal obesity among U.S. adults / C.Li, E.S.Ford, L.C. McGuire, A.H.Mokdad // Obesity. - 2007. - Vol. 15, Is. 1. - P. 216-224.


35. Faloia E. Inflammation as a link between obesity and metabolic syndrome / E.Faloia, G.Michetti, M.De Robertis et al. // J. Nutr. Metabolism. - 2012. - Vol. 2012. - Art. ID 476380, (7 p.).


36. Shields M. Abdominal obesity and cardiovascular disease risk factors within body mass index categories / M.Shields, M.S.Tremblay, S.Connor Gorber, I.Janssen // Health Rep. - 2012. - Vol. 23, N 2. - P. 7-15.


37. Sahakyan K. Normal-weight central obesity and cardiovascular mortality risk in hypertensive patients / K.Sahakyan, V.Somers, J.Rodriguez-Escudero et al. // J. Amer. Coll. Cardiol. - 2013. - Art. 61(10_S).


38. Galic S. Adipose tissue as an endocrine organ / S.Galic, J.S.Oakhilla, G.R.Steinberg // Mol. Cell. Endocrinol. - 2010. - Vol. 316, Is. 2. - P. 129-139.


39. Emanuela F. Inflammation as a link between obesity and metabolic syndrome / F.Emanuela, M.Grazia, De R.Marco et al. // J. Nutr. Metabolism. - 2012. - Vol. 2012. - Art. ID 476380, (7 p.).


40. Lumeng C.N. Inflammatory links between obesity and metabolic disease / C.N.Lumeng, A.R.Saltiel // J. Clin. Invest. - 2011. - Vol. 121, N 6. - P. 2111-2117.


41. Hotamisligil G.S. Inflammation and metabolic disorders / G.S.Hotamisligil // Nature. - 2006. - Vol. 444, N 7121. - P. 860-867.